icad Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,608.00
1,009.00
32,447.00
10,099.00
14,256.00
9,017
Depreciation, Depletion & Amortization
2,430.00
3,526.00
3,348.00
2,305.00
1,489.00
708
Other Funds
28.00
110.00
87.00
114.00
241.00
1,912
Funds from Operations
318.00
4,522.00
3,197.00
5,483.00
3,393.00
6,409
Changes in Working Capital
1,115.00
1,318.00
5,097.00
5.00
3,944.00
2,542
Net Operating Cash Flow
1,433.00
3,204.00
1,900.00
5,478.00
7,337.00
3,867
Capital Expenditures
707.00
1,264.00
972.00
349.00
395.00
Net Investing Cash Flow
707.00
4,746.00
2,672.00
355.00
2,455.00
Issuance/Reduction of Debt, Net
46.00
8,505.00
12,647.00
946.00
5,846.00
Net Financing Cash Flow
72.00
21,882.00
12,368.00
862.00
5,684.00
Net Change in Cash
2,068.00
20,340.00
16,940.00
6,695.00
802.00
Free Cash Flow
1,972.00
1,990.00
2,832.00
5,815.00
7,727.00
Deferred Taxes & Investment Tax Credit
-
-
-
7.00
8.00
12
Net Assets from Acquisitions
-
3,482.00
1,700.00
6.00
-
Other Sources
-
-
-
-
2,850.00
Change in Capital Stock
146.00
30,497.00
366.00
198.00
79.00

About icad

View Profile
Address
98 Spit Brook Road
Nashua New Hampshire 03062
United States
Employees -
Website http://www.icadmed.com
Updated 07/08/2019
iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy business segments. The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging.